Search
Filter by Topic
- Reproduction (22) Apply Reproduction filter
- Technologies (10) Apply Technologies filter
- People (8) Apply People filter
- Experiments (3) Apply Experiments filter
- Processes (3) Apply Processes filter
- Publications (3) Apply Publications filter
- Theories (3) Apply Theories filter
- Disorders (2) Apply Disorders filter
- Organizations (2) Apply Organizations filter
- Outreach (2) Apply Outreach filter
- Ethics (1) Apply Ethics filter
- Legal (1) Apply Legal filter
- Reproductive Health Arizona (1) Apply Reproductive Health Arizona filter
Progestin: Synthetic Progesterone
Progestin is a synthetic form of progesterone, a naturally occurring hormone, which plays an important role in the female reproductive cycle. During the 1950s two types of progestin that were later used in birth control pills were created, norethindrone and norethynodrel. In 1951 Carl Djerassi developed norethindrone at Syntex, S.A. laboratories located in Mexico City, receiving a patent on 1 May 1956. In 1953 Frank Colton developed norethynodrel at G.D. Searle and Company laboratories located in Chicago, receiving a patent on 29 November 1955.
Format: Articles
Subject: Technologies, Reproduction
“Diethylstilbestrol in the Prevention and Treatment of Complications of Pregnancy” (1948), by Olive Watkins Smith
In 1948, Olive Watkins Smith published 'Diethylstilbestrol in the Prevention and Treatment of Complications of Pregnancy' in the American Journal of Obstetrics and Gynecology. In 632 women treated with diethylstilbestrol, Smith demonstrated that the drug stimulated the production of progesterone, a hormone that regulates the uterine condition during pregnancy.
Format: Articles
Subject: Publications
Charles Raymond Greene (1901–1982)
Charles Raymond Greene studied hormones and the effects of environmental conditions such as high-altitude on physiology in the twentieth century in the United Kingdom. Green researched frostbite and altitude sickness during his mountaineering expeditions, helping to explain how extreme environmental conditions effect respiration. Greene’s research on hormones led to a collaboration with physician Katarina Dalton that culminated in the development of the theory that progesterone caused premenstrual syndrome, a theory that became the basis for later research on the condition.
Format: Articles
Subject: People
The Development of Mifepristone for Use in Medication Abortions
In the 1980s, researchers at the pharmaceutical company Roussel-Uclaf in Paris, France, helped develop a biological compound called mifepristone. When a woman takes it, mifepristone interferes with the function of hormones involved in pregnancy and it can therefore be used to terminate pregnancies. In 2000, the US Food and Drug Administration approved mifepristone, also called RU 486, as part of a treatment to induce abortions using drugs instead of surgery, a method called medication abortion.
Format: Articles
Subject: Reproduction
Action of MER-25 and of Clomiphene on the Human Ovary (1963)
Between 1958 and 1962, physicians Olive W. Smith, George V. Smith, and Robert W. Kistner performed experiments that demonstrated the effects of the drugs MER-25 and clomiphene citrate on the female human body. MER-25 and clomiphene citrate are drugs that affect estrogen production in women. At the time of the experiment, researchers did not know which organ or organs the drugs affected, the ovaries and/or the anterior pituitary gland.
Format: Articles
Subject: Experiments
"The Premenstrual Syndrome" (1953), by Raymond Greene and Katharina Dalton
In 1953, Raymond Greene and Katharina Dalton, who were doctors in the UK, published The Premenstrual Syndrome in the British Medical Journal. In their article, Dalton and Greene established the term premenstrual syndrome (PMS). The authors defined PMS as a cluster of symptoms that include bloating, breast pain, migraine-headache, fatigue, anxiety, depression, and irritability. The article states that the symptoms begin one to two weeks before menstruation during the luteal phase of the menstrual cycle, and they disappear upon the onset of the menstrual period.
Format: Articles
Subject: Publications, Reproduction
Katharina Dorothea Dalton (1916–2004)
Katharina Dorothea Dalton was a physician in England in the twentieth century who defined premenstrual syndrome (PMS) as a cluster of symptoms suspected to begin one to two weeks before menstruation and disappear upon the onset of a new menstrual cycle. Prior to Dalton, there was little research on pre-menstrual issues and those that existed linked the problem to excessive water retention or estrogen. Dalton hypothesized that PMS resulted from a deficiency in the hormone progesterone and advocated for hormone replacement therapy to lessen the symptoms of the syndrome.
Format: Articles
Subject: People
“Cardiovascular Risk Associated With the Use of an Etonogestrel-Containing Vaginal Ring” (2013), by Jürgen Dinger, Sabine Möhner, and Klaas Heinemann
In October 2013, Jürgen Dinger, Sabine Möhner, and Klaas Heinemann published the article “Cardiovascular Risk Associated With the Use of an Etonogestrel-Containing Vaginal Ring,” hereafter “Cardiovascular Risk,” in the journal Obstetrics and Gynecology. The authors enrolled patients in the study who were new users of either a vaginal contraceptive ring known as NuvaRing or a combined oral contraceptive pill. A combined oral contraceptive pill contains a formulation of the hormones progesterone and estrogen.
Format: Articles
Subject: Technologies, Reproduction
Amenorrhea as a Menstrual Disorder
Amenorrhea is considered a type of abnormal menstrual bleeding characterized by the unexpected absence of menstrual bleeding, lasting three months or longer. Menstrual bleeding typically happens approximately once a month when blood and endometrial tissue, or tissue lining the inside of the uterus, sheds from the uterus through the vagina. Menstruation is expected to stop with pregnancy, breastfeeding, and menopause, or the natural cessation of the menstrual cycle at an older age.
Format: Articles
Subject: Disorders, Reproduction
NuvaRing
The NuvaRing is a self-administered hormonal contraceptive device in the form of a flexible plastic ring that is inserted into the vagina. It releases the hormones etonogestrel and ethinylestradiol, which are synthetic forms of the female reproductive hormones progesterone and estrogen, respectively. The pharmaceutical company Organon first made NuvaRing in the Netherlands in 1980s. The Netherlands first approved it for use in February of 2001, and the United States did the same in October of that year.
Format: Articles
Subject: Technologies, Reproduction, Legal
Hormone Releasing Intrauterine Devices
Hormone releasing intrauterine devices or hormonal IUDs are contraceptive devices placed in a woman’s uterus to prevent pregnancy by continuously releasing a low dose of certain hormones. Jouri Valter Tapani Luukkainen, a medical researcher at the University of Helsinki, introduced the first hormonal IUD in 1976. Luukkainen’s IUD was a plastic device shaped like a capital T.
Format: Articles
Subject: Technologies
Gregory Goodwin Pincus (1903-1967)
Gregory Goodwin Pincus, one of the original researchers responsible for the development of the first oral contraceptive pill, was born in Woodbine, New Jersey, on 19 April 1903 to Russian Jewish parents. In 1924 Pincus received his BS degree from Cornell University, and in 1927 he received his MS and PhD from Harvard University, having studied under William Ernest Castle and William John Crozier.
Format: Articles
Subject: People, Reproduction
John Charles Rock (1890-1984)
Born on 24 March 1890 in Marlborough, Massachusetts, to Ann and Frank Rock, John Charles Rock was both a devout Catholic and one of the leading investigators involved in the development of the first oral contraceptive pill. In 1925 he married Anna Thorndike, with whom he later had five children. He spent over thirty years of his career as a clinical professor of obstetrics at Harvard Medical School, and in 1964 the Center for Population Studies of the Harvard School of Public Health established the John Rock Professorship.
Format: Articles
Subject: People, Reproduction
The Birth Control Pill
The birth control pill, more commonly known as "the pill" is a form of contraception taken daily in pill form and consisting of synthetic hormones formulated to prevent ovulation, fertilization, and implantation of a fertilized egg. The US Food and Drug Administration (FDA) approved the first birth control pill, Enovid, in June 1960. It was the first contraceptive pill marketed worldwide. Since then a number of different pills have been developed, which differ in hormone type and dosage, and whether they contain one hormone (the minipill) or two (the combination pill).
Format: Articles
Subject: Technologies, Reproduction
Estrogen and the Menstrual Cycle in Humans
Estrogen is the primary sex hormone in women and it functions during the reproductive menstrual cycle. Women have three major types of estrogen: estrone, estradiol, and estriol, which bind to and activate receptors within the body. Researchers discovered the three types of estrogen over a period of seven years, contributing to more detailed descriptions of the menstrual cycle. Each type of estrogen molecule contains a slightly different arrangement or number of atoms that in turn causes some of the estrogens to be more active than others.
Format: Articles
Subject: Theories, Reproduction
The Whelan Method of Sex Selection
The Whelan Method of Sex Selection is a method for increasing a couple’s probability of conceiving an infant of the desired sex through timing intercourse. Elizabeth Whelan, a public health researcher, suggested that couples only have intercourse at specific times during the woman’s menstrual cycle based on whether they wanted a female or male infant. Whelan published her method in her book, Boy or Girl, in 1977.
Format: Articles
Subject: Technologies
The Aschheim-Zondek Test for Pregnancy
Throughout history many different methods have been devised for the early detection of pregnancy. From the time of the Ancient Egyptians, inspection of the urine has been a popular place to start. However, it was not until the discovery of hormones in the early twentieth century that the development of truly reliable pregnancy tests occurred. Prior to 1978, when the first home pregnancy tests became available in the United States, pregnancy testing was done in hospital laboratories using various methods, one of them being the Aschheim-Zondek, or A-Z test.
Format: Articles
Subject: Technologies, Reproduction
Enovid: The First Hormonal Birth Control Pill
Enovid was the first hormonal birth control pill. G. D. Searle and Company began marketing Enovid as a contraceptive in 1960. The technology was created by the joint efforts of many individuals and organizations, including Margaret Sanger, Katharine McCormick, Gregory Pincus, John Rock, Syntex, S.A. Laboratories, and G.D. Searle and Company Laboratories.
Format: Articles
Subject: Technologies, Reproduction
Georgeanna Seegar Jones (1912-2005)
Georgeanna Seegar Jones was a reproductive endocrinologist who created one of America' s most successful infertility clinics in West Virginia and eventually, along with her husband Howard W. Jones MD, performed the first in vitro fertilization in America, leading to the birth of Elizabeth Jordan Carr. Jones was born in Baltimore, Maryland, on 6 July 1912. Her father, Dr. John King Beck Emory Seegar, was a practicing physician at the time working in the field of obstetrics.
Format: Articles
Subject: People, Reproduction
Plan B: Emergency Contraceptive Pill
Plan B is a progestin-only emergency contraceptive pill (ECP) that can be taken within seventy-two hours of unprotected sex in order to prevent an unwanted pregnancy. Plan B was created in response to the United States Food and Drug Administration's (US FDA) 1997 request for new drug applications (NDAs) for a dedicated ECP product, and was approved for sales in the US in 1999. Duramed, a subsidiary of Barr Pharmaceuticals, manufactures Plan B for The Women's Capital Corporation (WCC), which owns the patent for Plan B.
Format: Articles
Subject: Technologies, Reproduction
Min Chueh Chang (1908-1991)
As one of the researchers involved in the development of the oral contraceptive pill, Min Chueh Chang helped to revolutionize the birth control movement. Although best known for his involvement with "the pill," Chang also made a number of discoveries throughout his scientific career involving a range of topics within the field of reproductive biology. He published nearly 350 articles in scientific journals.
Format: Articles
Subject: People, Reproduction
Purkinje Cells
Purkinje cells, also called Purkinje neurons, are neurons in vertebrate animals located in the cerebellar cortex of the brain. Purkinje cell bodies are shaped like a flask and have many threadlike extensions called dendrites, which receive impulses from other neurons called granule cells. Each cell also has a single projection called an axon, which transmits impulses to the part of the brain that controls movement, the cerebellum. Purkinje cells are inhibitory neurons: they secrete neurotransmitters that bind to receptors that inhibit or reduce the firing of other neurons.
Format: Articles
Subject: Theories
Pregnancy Tests
Throughout history methods involving urine have been a popular way to test for pregnancy. Early ideas ranged from simply observing the color of a woman's urine to the notion that the urine of pregnant women contains special crystals or secretions. Indeed, pregnancy testing can be traced back to 1350 BCE in Ancient Egypt. A written document from the time describes a process in which a woman would urinate on wheat and barley seeds over several days and, depending on which plant grew, both the woman's pregnancy status and the sex of the fetus could be determined.
Format: Articles
Subject: Technologies, Reproduction
Abortion
Abortion is the removal of the embryo or fetus from the womb, before birth can occur-either naturally or by induced labor. Prenatal development occurs in three stages: the zygote, or fertilized egg; the embryo, from post-conception to eight weeks; and the fetus, from eight weeks after conception until the baby is born. After abortion, the infant does not and cannot live. Spontaneous abortion is the loss of the infant naturally or accidentally, without the will of the mother. It is more commonly referred to as miscarriage.
Format: Articles
Subject: Processes, Ethics, Reproduction
The Process of Implantation of Embryos in Primates
Implantation is a process in which a developing embryo, moving as a blastocyst through a uterus, makes contact with the uterine wall and remains attached to it until birth. The lining of the uterus (endometrium) prepares for the developing blastocyst to attach to it via many internal changes. Without these changes implantation will not occur, and the embryo sloughs off during menstruation. Such implantation is unique to mammals, but not all mammals exhibit it.
Format: Articles
Subject: Processes